Intra-Cellular Therapies, Inc. (ITCI)
131.87
0.00 (0.00%)
Inactive · Last trade price on Apr 1, 2025

Intra-Cellular Therapies Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
14,0218,8556,8935,0124,2642,549
Market Cap Growth
-28.46%37.53%17.54%67.27%34.44%
Enterprise Value
13,0377,8666,4174,4093,8131,856
Last Close Price
131.8783.5271.6252.9252.3431.80

Price Ratios

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
PS Ratio
19.9713.0114.8420.0250.88111.74
PB Ratio
12.207.7111.657.6410.203.88
P/TBV Ratio
12.217.7111.657.6410.203.88

EV Ratios

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
EV/Sales Ratio
19.1511.5513.8217.6245.5081.37

Financial Efficiency

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Debt / Equity Ratio
0.020.020.030.030.060.04
Asset Turnover
0.650.650.630.400.140.05
Inventory Turnover
15.4515.4512.039.7412.91-
Quick Ratio
5.705.704.978.018.1118.13
Current Ratio
6.366.365.418.878.7618.75
Return on Equity (ROE)
-8.58%-8.58%-22.39%-47.72%-52.87%-53.30%
Return on Assets (ROA)
-6.96%-6.96%-13.43%-26.47%-29.58%-29.84%
Return on Invested Capital (ROIC)
-8.22%-8.22%-15.51%-29.44%-31.62%-31.97%

Yields

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Earnings Yield
-0.53%-0.84%-2.03%-5.11%-6.66%-8.91%
FCF Yield
-0.52%-0.83%-1.81%-5.41%-6.09%-9.04%
Buyback Yield / Dilution
-7.56%-7.56%-1.95%-15.75%-15.47%-27.50%
SEC Filings: 10-K · 10-Q